AirNexis Therapeutics, Inc. — Form D

AirNexis Therapeutics, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-09. The offering totals $200.0M, of which $62.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-03-09
• Form: D
• Accession: 0002116194-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $200.0M
• Amount sold: $62.0M
• Remaining: $138.0M
• Investors: 13
• Date of first sale: 2026-01-09
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-575781

Issuer

• Name: AirNexis Therapeutics, Inc.
• CIK: 0002116194
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2024
• Address: 1001 PAGE MILL ROAD, PALO ALTO, CA, 94304
• Phone: (619) 604-7904

Officers, directors & promoters (8)

More

• CIK 2116194 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search